Case/Reference | Year of Publication | First Author | Patient age | Patient Gender | Etiology | Location of CD | Activity of CD | Location of rash | Therapy | Recurrence Y/N |
---|---|---|---|---|---|---|---|---|---|---|
1 [10] | 1996 | Zlatanic | 39 | M | CD | Transverse and sigmoid colon | Active | Legs | IV hydrocortisone | N |
2 [11] | 2002 | McIlwain | 24 | F | Infliximab | Terminal ileum | Active | Legs and arms | Methylprednisolone | N |
3 [12] | 2008 | Tsiamoulous | 80 | M | CD | Colon | Initial manifestation (active) | Legs | IV Prednisolone | N |
4 [113] | 2010 | Limdi | 52 | M | CD | Ileum | Quiescent | Legs | IV steroids | N |
5 [14] | 2013 | Karatoprak | 28 | M | CD | Jejunum | Initial manifestation (active) | Legs | Prednisone | N |
6 [15] | 2016 | Namakura | 35 | M | Infliximab | NR | Quiescent | Legs | Spontaneous resolution | N |
7 [16] | 2017 | Bernardes | 29 | F | Adalimumab | Colon | NR | Legs and abdomen | Discontinuation of Adalimumab | Y |
8 [16] | 2017 | Bernardes | 60 | M | Adalimumab | Ileocolon | NR | Legs | Discontinuation of Adalimumab | N |
9 [16] | 2017 | Bernardes | 44 | F | Adalimumab | Colon | NR | Legs | Discontinuation of Adalimumab | Y |
10 [17] | 2017 | Goncalves | 51 | M | CD | Sigmoid and rectum | Initial manifestation (active) | Legs, thighs, arms | Prednisone | Y |
11 [18] | 2017 | Woody | 28 | F | Certolizumab | NR | NR | Legs, feet, palms | Prednisone, Dapsone | N |
12 [19] | 2017 | Cury | 28 | F | Adalimumab | NR | Quiescent | Legs | Colchicine | N |
13 [20] | 2018 | Fonseca | 38 | F | Infliximab | Ileum | Quiescent | Legs | Prednisone | N |
14 [21] | 2019 | Costa-Moreira | 28 | F | Ustekinumab | Perianal | Quiescent | Legs and abdomen | Prednisone | Y |